KR101238963B1 - Skin whitening composition comprising complex herbal extract - Google Patents

Skin whitening composition comprising complex herbal extract Download PDF

Info

Publication number
KR101238963B1
KR101238963B1 KR1020100093236A KR20100093236A KR101238963B1 KR 101238963 B1 KR101238963 B1 KR 101238963B1 KR 1020100093236 A KR1020100093236 A KR 1020100093236A KR 20100093236 A KR20100093236 A KR 20100093236A KR 101238963 B1 KR101238963 B1 KR 101238963B1
Authority
KR
South Korea
Prior art keywords
acid
extract
oil
lotion
tyrosinase
Prior art date
Application number
KR1020100093236A
Other languages
Korean (ko)
Other versions
KR20120031696A (en
Inventor
손준호
박태순
정미송
김희정
황주영
김동희
황은영
Original Assignee
서미자
재단법인 한국한방산업진흥원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서미자, 재단법인 한국한방산업진흥원 filed Critical 서미자
Priority to KR1020100093236A priority Critical patent/KR101238963B1/en
Publication of KR20120031696A publication Critical patent/KR20120031696A/en
Application granted granted Critical
Publication of KR101238963B1 publication Critical patent/KR101238963B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 복합생약 추출물을 유효성분으로 함유하는 조성물에 관한 것으로, 구체적으로 우수한 티로시나제 저해활성을 나타내고, B16F10 melanoma 세포 내 실험에서 멜라닌 합성 저해 활성을 나타내는바 본 발명의 복합생약 추출물은 미백 효과를 갖는 피부외용 약학조성물 및 화장료 조성물로 유용하게 이용될 수 있다.The present invention relates to a composition containing a complex herbal extract as an active ingredient, specifically exhibits excellent tyrosinase inhibitory activity, and shows a melanin synthesis inhibitory activity in B16F10 melanoma cell experiments. It can be usefully used as an external skin pharmaceutical composition and cosmetic composition.

Description

복합생약 추출물을 유효성분으로 함유하는 피부미백용조성물 {Skin whitening composition comprising complex herbal extract}Skin whitening composition containing complex herbal extract as active ingredient {Skin whitening composition comprising complex herbal extract}

본 발명은 복합생약 추출물을 유효성분으로 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening containing a complex herbal extract as an active ingredient.

[문헌 1] Ando, S., O. Ando, Y. Suemoto, and Mishima Y. 1993. Tyrosinase gene transcription and its control by melanogenic inhibitors. J Invest Dermatol 100, 150S-155S. 1, Ando, S., O. Ando, Y. Suemoto, and Mishima Y. 1993. Tyrosinase gene transcription and its control by melanogenic inhibitors. J Invest Dermatol 100, 150S-155S.

[문헌 2] Aroca, P., K. Urabe, K. Kobayashi, K. Taskamoto, and V. J. Hearing. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655.References 2 Aroca, P., K. Urabe, K. Kobayashi, K. Taskamoto, and V. J. Hearing. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655.

[문헌 3] Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosen- sitivity testing. Cancer Res . 47, 936-942.[3] Carmichael, J., WG DeGraff, AF Gazdar, JD Minna, and JB Mitchell. 1987.Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosen- sitivity testing. Cancer Res . 47 , 936-942.

[문헌 4] Chin, J. E., and N. C. Cho. 2005. Effects of Houttuynia cordata extracts on tyrosinse gene expression. J. Korean Soc Food Sci Nutr 34, 1284-1288. 7[4] Chin, J. E., and N. C. Cho. 2005. Effects of Houttuynia cordata extracts on tyrosinse gene expression. J. Korean Soc Food Sci Nutr 34, 1284-1288. 7

[문헌 5] Choi, B.W., B. H. Lee, K. J. Kang, E. S. Lee and N. H. Lee. 1998. Screening of the tyrosinase inhibitors from marine algae and medicinal plants. Kor J Pharmacogn. 29. 237-242.[Reference 5] Choi, B.W., B. H. Lee, K. J. Kang, E. S. Lee and N. H. Lee. 1998. Screening of the tyrosinase inhibitors from marine algae and medicinal plants. Kor J Pharmacogn. 29. 237-242.

[문헌 6] Ge, R. Y., C. H. Zhou, and Y. C. She. 1983. Influences of stigma croci and semen persicae on function of ovary-uterus in pseudopregnant rats. J Tra Chinese Med 3, 23-26. [Reference 6] Ge, R. Y., C. H. Zhou, and Y. C. She. 1983. Influences of stigma croci and semen persicae on function of ovary-uterus in pseudopregnant rats. J Tra Chinese Med 3, 23-26.

[문헌 7] Hosoi, J., E. Abe, T. Suda and T. Kuroki. 1985. Regulation of melanin synthesis of B16 melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. J. cancer. Res. 45, 1474-1478.7 Hosoi, J., E. Abe, T. Suda and T. Kuroki. 1985.Regulation of melanin synthesis of B16 melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. J. cancer. Res. 45, 1474-1478.

[문헌 8] Imokawa, G. and Y. Mishima. 1982. Loss of melanogenic properties in tyrosinase induced by glucosylation inhibitors within malignant melanoma cells. Cancer Res 42,1994-2002.[Reference 8] Imokawa, G. and Y. Mishima. 1982. Loss of melanogenic properties in tyrosinase induced by glucosylation inhibitors within malignant melanoma cells. Cancer Res 42,1994-2002.

[문헌 9] Jimenez-Cervantes C., F. Solano, T. Kobayashi, K. Urabe, V. J. Hearing, J. Lozano, and C. Garcia-Borron. 1994. A new enzymatic function in the melanogenic pathway. J. Biol Chem 269, 17993-18001.9 References Jimenez-Cervantes C., F. Solano, T. Kobayashi, K. Urabe, V. J. Hearing, J. Lozano, and C. Garcia-Borron. 1994. A new enzymatic function in the melanogenic pathway. J. Biol Chem 269, 17993-18001.

[문헌 10] Kim, S. J., D. H. Kweon, and J. H. Lee. 2006. Investigation of antioxidative activity and stability of ethanol extracts of Licorice Root(Glychrrhiza glabra). Korean J Food Sci Technol 38, 584-588.10. Kim, S. J., D. H. Kweon, and J. H. Lee. 2006. Investigation of antioxidative activity and stability of ethanol extracts of Licorice Root (Glychrrhiza glabra). Korean J Food Sci Technol 38, 584-588.

[문헌 11] Kosuge, T., H. Ishida, and M. Ishii. 1985. Studies on active substances in the herbs used for oketsu in chinese medicine. Ⅱ. On the anticoagulative pronciple in persicae seme. J Chem Pham Bull 33, 1496-1498. 11 Kosuge, T., H. Ishida, and M. Ishii. 1985. Studies on active substances in the herbs used for oketsu in chinese medicine. Ⅱ. On the anticoagulative pronciple in persicae seme. J Chem Pham Bull 33, 1496-1498.

[문헌 12] Lee, P. J. 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell. J. Kor Plant Res 22, 477-482.[12] Lee, P. J. 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell. J. Kor Plant Res 22, 477-482.

[문헌 13] Lee, Y. H., S. S. Park, S. W. Lee, S. H. Lee, K. H. Park, Y. J. Choi, and S. W. Gal. 2006. Whitening effect of mycelial cuture broth of paecilomyces japonica in the mixture of cucumber and grape extracts. J Life Science 16, 870-875. 13, Lee, Y. H., S. S. Park, S. W. Lee, S. H. Lee, K. H. Park, Y. J. Choi, and S. W. Gal. 2006.Whitening effect of mycelial cuture broth of paecilomyces japonica in the mixture of cucumber and grape extracts. J Life Science 16, 870-875.

[문헌 14] Lin, C. B., L. Babiarz, F. Liebel, E. Roydon Price, M. Kizoulis, G. J. Gendi menico, D. E. Fisher, and M. Seiberg. 2002. Modulation of microphthal mia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol 119, 1330-1340.14, Lin, C. B., L. Babiarz, F. Liebel, E. Roydon Price, M. Kizoulis, G. J. Gendi menico, D. E. Fisher, and M. Seiberg. 2002. Modulation of microphthal mia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol 119, 1330-1340.

[문헌 15] Michikawa, M., K.T. Lim, J. G. McLarnon and S. U. Kim. 1994. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci Res. 37, 62-70. Reference 15 Michikawa, M., K.T. Lim, J. G. McLarnon and S. U. Kim. 1994. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci Res. 37, 62-70.

[문헌 16] Mun, Y. J., J. Kim, N. Y. Lim, S. Y. Lee, S. Gwak, C. Y. Hwang, and W. H. Woo. 2002. Korean J Oriental Physiology & Pathology 16, 1230-1235. [16] Mun, Y. J., J. Kim, N. Y. Lim, S. Y. Lee, S. Gwak, C. Y. Hwang, and W. H. Woo. 2002. Korean J Oriental Physiology & Pathology 16, 1230-1235.

[문헌 17] Park, H. J., J. S. Lee, J. D. Lee, N. J. Kim, J. H. Pyo, J. M. Kang, I. H. Choe, S. Y. Kim, B. S. Shim, J. H. Lee, and Sabina Lim. 2005. The anti inflammatory effect of Cinnamomi Ramulus. J Korean Oriental Med 26, 140-151.17. Park, H. J., J. S. Lee, J. D. Lee, N. J. Kim, J. H. Pyo, J. M. Kang, I. H. Choe, S. Y. Kim, B. S. Shim, J. H. Lee, and Sabina Lim. 2005. The anti inflammatory effect of Cinnamomi Ramulus. J Korean Oriental Med 26, 140-151.

[문헌 18] Park, S. M., G. W. Lee, and Y. H. Cho. 2008. Effects of Rheum undulatum extract on antioxidant activity and activity of matrix metalloproteinase-1 in human skin fibroblasts. J Life science 18, 1700-1704.18. Park, S. M., G. W. Lee, and Y. H. Cho. 2008.Effects of Rheum undulatum extract on antioxidant activity and activity of matrix metalloproteinase-1 in human skin fibroblasts. J Life science 18, 1700-1704.

[문헌 19] Paval, S. 1993. Dynamics of melanogenesis intermediates. J. Invest Dermatology 100, 162-165.19 Paval, S. 1993. Dynamics of melanogenesis intermediates. J. Invest Dermatology 100, 162-165.

[문헌 20] Sakamoto, S., H. Kudo, T. Kawasaki, K. Kuwa, N. Kasahara, S. Sassa, and R. Okamoto. 1988. Effects of a chinese herbal medicine, keishi-bukuryo-gan on the gonadal of rats. J Ethnophamacol 23, 151-158.20. Sakamoto, S., H. Kudo, T. Kawasaki, K. Kuwa, N. Kasahara, S. Sassa, and R. Okamoto. 1988.Effects of a chinese herbal medicine, keishi-bukuryo-gan on the gonadal of rats. J Ethnophamacol 23, 151-158.

[문헌 21] Tomohiro, I. and F. Yukio. 2005 Hot water extracts from Adzuki Beans(vigna angularis) stimulate not only melanogensis in cultured mouse B16 melanoma cells but also pigmentation of hair color in C3H mice. BioSci. Biotechnol. Biochem. 69, 873-882.[21] Tomohiro, I. and F. Yukio. 2005 Hot water extracts from Adzuki Beans (vigna angularis) stimulate not only melanogensis in cultured mouse B16 melanoma cells but also pigmentation of hair color in C3H mice. BioSci. Biotechnol. Biochem. 69, 873-882.

[문헌 22] Voegeli, R. 1996. Elastase and typtase determination on human skin surface. Cosmetic &Toiletries. 111, 51-58.
22. Voegeli, R. 1996. Elastase and typtase determination on human skin surface. Cosmetic & Toiletries. 111, 51-58.

현대인들은 자외선, 스트레스 등의 여러 가지 내외적인 요인에 의해 각종 피부 트러블 유발로 기미, 주근깨, 피부 색소 침착 등의 피부 노화 현상을 촉진한다(Voegeli, R. 1996. Elastase and typtase determination on human skin surface. Cosmetic &Toiletries. 111, 51-58.). 피부의 색소 침착은 멜라닌 색소가 생합성에서 티로시나제(tyrosinase) 효소를 비롯하여 DHICA oxidase(TRP-1)등의 L-tyrosine을 DOPA(3,4-dihydroxyphenyla-lanine)으로 DOPA에서 DOPA quinone으로 초기반응을 조절하는 것으로 알려져 있다(Aroca, P., et al. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655.; Jimenez-Cervantes C., et al. 1994. A new enzymatic function in the melanogenic pathway. J. Biol Chem 269, 17993-18001.; Paval, S. 1993. Dynamics of melanogenesis intermediates. J. Invest Dermatology 100, 162-165.). 이를 바탕으로 티로시나제(tyrosinase) 효소의 활성을 저해하여 멜라닌 생합성의 억제에 영향을 미칠 수 있는 천연물 탐색에 대한 연구가 활발히 진행되고 있다. 그 결과 어성초 추출물을 이용하여 티로시나제(tyrosinase) 유전자 발현 억제 효과(Chin, J. E., et al. 2005. Effects of Houttuynia cordata extracts on tyrosinse gene expression. J. Korean Soc Food Sci Nutr 34, 1284-1288.), 머루 포도씨 추출물의 α-MSH으로 자극한 B16세포에서 멜라닌(melanin) 생성억제 효과(Lee, P. J. 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell. J. Kor Plant Res 22, 477-482.) 등 천연물을 활용한 연구가 활발히 이뤄지고 있다. 그 외 현재 알려져 있는 항산화 및 미백원료는 아르부틴(Arbutin), 코지산(Kojic acid), 아스코르브산(Ascorbic acid) 등의 물질이 대표적이고 상백피, 닥나무, 감초 등의 식물 추출물이 널리 알려져 있다.Modern people promote various skin aging phenomena such as blemishes, freckles and skin pigmentation due to various internal and external factors such as ultraviolet rays and stress (Voegeli, R. 1996. Elastase and typtase determination on human skin surface. Cosmetic & Toiletries. 111, 51-58.). Pigmentation of skin regulates the initial reaction of melanin from biosynthesis to tyrosinase enzyme and L-tyrosine such as DHICA oxidase (TRP-1) with DOPA (3,4-dihydroxyphenyla-lanine) from DOPA to DOPA quinone. (Aroca, P., et al. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655 .; Jimenez-Cervantes C., et al. 1994. A new enzymatic function in the melanogenic pathway.J. Biol Chem 269, 17993-18001 .; Paval, S. 1993. Dynamics of melanogenesis intermediates.J. Invest Dermatology 100, 162-165.). Based on this, studies on natural products that may affect the inhibition of melanin biosynthesis by inhibiting the activity of tyrosinase enzymes are being actively conducted. As a result, the inhibitory effect of tyrosinase gene expression using Echochocho extract (Chin, JE, et al. 2005. Effects of Houttuynia cordata extracts on tyrosinse gene expression.J. Korean Soc Food Sci Nutr 34, 1284-1288.), Lee, PJ 2009. Inhibitory effect of muscat bailey a seed extract on melanin production in α-MSH stimulated B16 cell.J. Kor Plant Res 22, 477-482.) Research using natural products is being actively conducted. In addition, currently known antioxidants and whitening materials are representatives such as arbutin, Kojic acid, ascorbic acid, and plant extracts such as baekbaekpi, mulberry, licorice.

천연약재의 복합처방으로 대황, 계지, 감초, 도인, 망초등 5가지 한약재로 구성되어 있다. 복합생약 추출물을 구성하는 약재 중 대황은 마디풀과에 속하는 다년생 초본 식물로 뿌리를 건조시켜 약재로 사용한다. 대황은 외용약으로 화상치료와 피부병에 이용되며 이는 농도의존적으로 뛰어난 항산화 활성을 가지고 있으며 MMP-1의 활성 저해효과가 보고되었다(Park, S. M., et al. 2008. Effects of Rheum undulatum extract on antioxidant activity and activity of matrix metalloproteinase-1 in human skin fibrob). 계지는 계피나무의 어린가지를 말린 것으로, 신남알데히드(cinnamaldehyde), 쿠마린(coumarin), β-시토스테롤(sitosterol), 프로토카테큐산(protocatechuic acid)등의 화학성분을 함유하며 염증반응에 대한 연구 결과 염증이 가해지면 생성되는 NO와 PGE2의 반응성 물질이 농도에 따라 저해되고 iNOS, COX-2와 같은 유전자 발현을 감소시킨다고 보고되었다[Park, H. J., et al. 2005. The anti inflammatory effect of Cinnamomi Ramulus. J Korean Oriental Med 26, 140-151.]. 도인은 복숭아씨로써 천연항산화제, 노화억제, 항암억제제로 오래전부터 여성의 질환과 퇴행성 질환 등에 사용되었으며 anti tumor promoter, 항 어혈 작용 등이 보고되어 있다(Ge, R. Y., et al. 1983. Influences of stigma croci and semen persicae on function of ovary-uterus in pseudopregnant rats. J Tra Chinese Med 3, 23-26.; Sakamoto, S., et al. 1988. Effects of a chinese herbal medicine, keishi-bukuryo-gan on the gonadal of rats. J Ethnophamacol 23, 151-158.; Kosuge, T., et al. 1985. Studies on active substances in the herbs used for oketsu in chinese medicine. Ⅱ. On the anticoagulative pronciple in persicae seme. J Chem Pham Bull 33, 1496-1498.). 감초는 스테로이드 호르몬과 유사한 작용이 있어 항염증작용, 해독작용, 해열작용을 한다. 항산화효과(Kim, S. J., et al. 2006. Investigation of antioxidative activity and stability of ethanol extracts of Licorice Root(Glychrrhiza glabra). Korean J Food Sci Technol 38, 584-588.)가 있으며 피부의 감염증에 사용되어졌다. 항자극제이며 색소제거 효과뿐만 아니라 티로시나제(tyrosinase) 억제제로 작용하여 멜라닌 합성을 억제하는 효과(Mun, Y. J., et al. 2002. Korean J Oriental Physiology & Pathology 16, 1230-1235.)가 있다. 이는 코직산보다 효능이 우수한 것으로 알려져 있다. 망초(Natrii sulfas)는 체내 사하작용을 하고 소화기 내의 점막을 기계적으로 자극하여 연동운동이 강해지는 것과 관련이 있다. It is a complex prescription of natural medicines and consists of five kinds of Chinese herbal medicines such as rhubarb, gyeji, licorice, doin, and mango. Rhubarb is a perennial herbaceous plant belonging to the Medicinalaceae, which is used as a medicinal herb. Rhubarb is an external medicine used for burn treatment and dermatological diseases. It has excellent concentration-dependent antioxidant activity and has been reported to inhibit MMP-1 activity (Park, SM, et al. 2008. Effects of Rheum undulatum extract on antioxidant activity and activity of matrix metalloproteinase-1 in human skin fibrob). Cinnamon is dried sprigs of cinnamon tree, and contains chemicals such as cinnamaldehyde, coumarin, β-sitosterol, and protocatechuic acid. This addition has been reported to inhibit the production of reactive substances of NO and PGE 2 produced by the concentration and to reduce gene expression such as iNOS, COX-2 [Park, HJ, et al. 2005. The anti inflammatory effect of Cinnamomi Ramulus. J Korean Oriental Med 26, 140-151.]. Peach Seed is a peach seed, a natural antioxidant, anti-aging and anti-cancer agent, which has been used for a long time in women's diseases and degenerative diseases, and has been reported for anti tumor promoter and anti-blood activity (Ge, RY, et al. 1983. Influences of stigma croci and semen persicae on function of ovary-uterus in pseudopregnant rats.J Tra Chinese Med 3, 23-26 .; Sakamoto, S., et al. 1988. Effects of a chinese herbal medicine, keishi-bukuryo-gan on the gonadal of rats.J Ethnophamacol 23, 151-158 .; Kosuge, T., et al. 1985. Studies on active substances in the herbs used for oketsu in chinese medicine.II.On the anticoagulative pronciple in persicae seme.J Chem Pham Bull 33, 1496-1498.). Licorice has a similar effect to steroid hormones, which are anti-inflammatory, detoxifying and antipyretic. Antioxidant effect (Kim, SJ, et al. 2006. Investigation of antioxidative activity and stability of ethanol extracts of Licorice Root (Glychrrhiza glabra) .Korean J Food Sci Technol 38, 584-588.) . It is an anti-irritant and has an effect of inhibiting melanin synthesis by acting as a tyrosinase inhibitor as well as a pigment removing effect (Mun, YJ, et al. 2002. Korean J Oriental Physiology & Pathology 16, 1230-1235.). It is known to be superior to kojic acid. Natrii sulfas are associated with stronger peristalsis by acting in the body and mechanically stimulating the mucous membranes in the digestive tract.

본 연구는 구성약재의 활성을 바탕으로 복합생약 추출물을 미백화장품 소재로 활용하기 위해 B16F10 melanoma 세포를 이용하여 멜라닌 함량 및 멜라닌 생합성에 관여하는 티로시나제(tyrosinase), TRP-1과 같은 단백질 발현에 대해 연구하였다. This study was conducted to study the expression of proteins such as tyrosinase and TRP-1, which are involved in melanin content and melanin biosynthesis, using B16F10 melanoma cells in order to utilize complex herbal extracts as whitening cosmetics based on the activity of constituents. It was.

이에 본 발명자들은 복합생약 추출물이 우수한 티로시나제 저해활성을 가짐을 확인함으로써 본 발명을 완성하였다.The present inventors completed the present invention by confirming that the complex herbal extract has excellent tyrosinase inhibitory activity.

상기 목적을 달성하기 위하여, 본 발명은 복합생약 추출물을 유효성분으로 함유하는 미백용 피부외용 약학조성물을 제공한다.In order to achieve the above object, the present invention provides a whitening skin external pharmaceutical composition containing a complex herbal extract as an active ingredient.

또한, 본 발명은 복합생약 추출물을 유효성분으로 함유하는 미백용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for whitening containing a complex herbal extract as an active ingredient.

본원에서 정의되는 복합생약 추출물은 대황, 계지, 감초, 도인 및 망초의 건조 혼합중량비(%)가 1~9 : 1~6 : 1~6 : 1~30 : 1~30, 바람직하게는 1~6 : 1~4 : 1~4 : 1~20 : 1~20로 구성됨을 포함한다.Complex herbal extracts defined herein have a dry mixed weight ratio (%) of rhubarb, gyeji, licorice, cabbage and manganese 1 to 9: 1 to 6: 1 to 6: 1 to 30: 1 to 30, preferably 1 to 6: 1-4: 1-4: 1-20: 1-20.

본원에서 정의되는“추출물”은 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 부틸렌글리콜, 프로필렌글리콜, 함수부틸렌글리콜, 함수프로필렌글리콜, 함수글리세린으로 구성된 그룹으로부터 선택된 하나 이상의 용매, 바람직하게는 물 및 에탄올, 가장 바람직하게는 60% 내지 80% 에탄올 가용 추출물을 포함한다. As used herein, an “extract” is one or more selected from the group consisting of water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, hydrobutylene glycol, hydrous propylene glycol, hydrous glycerin Solvents, preferably water and ethanol, most preferably 60% to 80% ethanol soluble extract.

상기 복합생약 추출물은 피부외용 약학조성물은 총 중량에 대하여 0.1 내지 50 중량%으로 포함함을 특징으로 한다.The complex herbal extract is characterized in that it contains 0.1 to 50% by weight based on the total weight of the skin external pharmaceutical composition.

상기 약학 조성물은 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플라스마제 제형을 포함한다. The pharmaceutical composition comprises a cream, gel, patch, spray, ointment, warning, lotion, linen, pasta or cataplasma formulation.

또한, 상기 화장료 조성물은 화장수, 스킨, 로션, 영양로션, 영양크림, 마사지 크림, 에센스, 팩의 제형을 포함한다.In addition, the cosmetic composition includes a lotion, skin, lotion, nutrition lotion, nutrition cream, massage cream, essence, the formulation of the pack.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 복합생약 추출물은 하기와 같이 수득될 수 있다.The herbal extract of the present invention can be obtained as follows.

본 발명의 대황, 계지, 감초, 도인 및 망초의 혼합중량비(%)가 1~9 : 1~6 : 1~6 : 1~30 : 1~30, 바람직하게는 1~6 : 1~4 : 1~4 : 1~20 : 1~20로 혼합하는 제 1단계; 상기 혼합물 중량의 약 1 내지 30배, 바람직하게는 약 1 내지 15배에 달하는 부피의 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 부틸렌글리콜, 프로필렌글리콜, 함수부틸렌글리콜, 함수프로필렌글리콜, 함수글리세린으로 구성된 그룹으로부터 선택된 하나 이상의 용매, 바람직하게는 물 및 에탄올, 바람직하게는 물을 첨가하여 약 10℃ 내지 100℃ 바람직하게는 30℃ 내지 90℃에서 약 1시간 내지 5시간 동안 열수 추출, 환류 냉각 추출, 침지 추출 또는 압력추출 등의 추출방법을 사용하여, 바람직하게는 환류 냉각 추출하는 제 2 단계; 상기 추출물을 1회 내지 5회 원심분리, 감압여과, 농축 및 동결건조 하는 제 3단계를 포함하는 제조방법을 통하여 본 발명의 복합생약 추출물을 수득할 수 있다.The mixed weight ratio (%) of rhubarb, cinnamon, licorice, cabbage and mango of the present invention is 1-9: 1-6: 1-6: 1-30: 1-30, preferably 1-6: 1-4: 1 to 4: 1 to 20: the first step of mixing in 1 to 20; Water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, hydrous butylene glycol in volumes of about 1 to 30 times, preferably about 1 to 15 times the weight of the mixture , At least one solvent selected from the group consisting of hydrous propylene glycol and hydrous glycerin, preferably water and ethanol, preferably water, about 10 ° C. to 100 ° C., preferably about 30 ° C. to 90 ° C., for about 1 hour to 5 hours. A second step of extracting preferably by reflux cooling using an extraction method such as hot water extraction, reflux cooling extraction, immersion extraction or pressure extraction for a time; The extract of the present invention may be obtained through the preparation method comprising the third step of centrifugation, vacuum filtration, concentration, and lyophilization of the extract 1 to 5 times.

또한, 대황, 계지, 망초, 감초, 도인은 오랫동안 생약 및 식용으로 사용되어 오던 약재로서 이들로부터 추출된 본 발명의 복합생약 추출물 역시 독성 및 부작용 등의 문제가 없으며, 피부 첩포 시험에서 무자극 시료임이 입증되었으므로 장기간 사용 시에도 안심하고 사용할 수 있다.In addition, rhubarb, cinnamon, forget-me-not, licorice, cabbage is a herb that has been used for a long time as a herbal medicine and edible, the herbal extract of the present invention extracted from them also has no problems such as toxicity and side effects, it is a non-irritant sample in skin patch test Proven, you can use it with confidence even for long time use.

본 발명의 복합생약 추출물을 함유하는 피부외용 약학조성물은 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플라스마제의 피부 외용제 형태의 약학조성물로 제조하여 사용할 수 있으나, 이에 한정하는 것은 아니다. The external skin pharmaceutical composition containing the complex herbal extract of the present invention is prepared as a pharmaceutical composition in the form of an external skin preparation of cream, gel, patch, spray, ointment, warning, lotion, linen, pasta or cataplasma. Can be used, but is not limited thereto.

본 발명의 복합생약 추출물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나 바람직한 효과를 위해서, 본 발명의 복합생약 추출물은 1일 0.0001 내지 100 ㎎/㎏으로, 바람직하게는 0.001 내지 10 ㎎/㎏으로 투여하는 것이 좋다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다. The preferred dosage of the complex herbal extract of the present invention depends on the condition and weight of the patient, the extent of the disease, the form of the drug, the route of administration and the duration, and may be appropriately selected by those skilled in the art. However, for the preferred effect, the composite herbal extract of the present invention is preferably administered at 0.0001 to 100 mg / kg, preferably at 0.001 to 10 mg / kg. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.

본 발명의 복합생약 추출물은 미백 효과를 갖는 화장품 및 세안제 등에 다양하게 이용될 수 있다.Complex herbal extract of the present invention can be used in a variety of cosmetics and face wash having a whitening effect.

본 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 화장수, 스킨, 로션, 영양로션, 영양크림, 맛사지크림, 에센스, 팩 등과 같은 화장품류와 클렌징, 세안제, 비누, 트리트먼트, 미용액 등이 있다.Products to which the composition can be added include, for example, cosmetics such as lotion, skin, lotion, nourishing lotion, nourishing cream, massage cream, essence, pack, etc., and cleansing, face wash, soap, treatment, essence, etc. have.

본 발명의 화장료는 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스로 이루어진 군에서 선택된 조성물을 포함한다.Cosmetics of the present invention comprises a composition selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymer polysaccharides, sphingolipids and seaweed extract.

수용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민 C, 비타민 H 등을 들 수 있으며, 그들의 염 (티아민염산염, 아스코르빈산나트륨염 등)이나 유도체 (아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 본 발명에서 사용할 수 있는 수용성 비타민에 포함된다. 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득할 수 있다.The water-soluble vitamins may be any compound that can be incorporated into cosmetics, but preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like. Their salts (thiamine hydrochloride, sodium ascorbate salt, etc.) and derivatives (ascorbic acid-2-sodium phosphate salt, ascorbic acid-2-magnesium phosphate salt, etc.) may also be used in the water-soluble vitamins that can be used in the present invention. Included. The water-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification from microorganism culture, enzyme or chemical synthesis.

유용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 A, 카로틴, 비타민 D2, 비타민 D3, 비타민 E (d1-알파 토코페롤, d-알파 토코페롤, d-알파 토코페롤) 등을 들 수 있으며, 그들의 유도체 (팔미틴산아스코르빈, 스테아르산아스코르빈, 디팔미틴산아스코르빈, 아세트산 dl-알파 토코페롤, 니코틴산 dl-알파 토코페롤비타민 E, dl-판토테닐알코올, D-판토테닐알코올, 판토테닐에틸에테르 등) 등도 본 발명에서 사용되는 유용성 비타민에 포함된다. 유용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소 또는 화학 합성법 등의 통상의 방법에 의해 취득할 수 있다.The oil-soluble vitamin may be any compound that can be incorporated into cosmetics, but preferably vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-alpha tocopherol, d-alpha tocopherol, d-alpha tocopherol), and the like. And derivatives thereof (ascorbic palmitate, ascorbic stearate, ascorbic acid dipalmitate, dl-alpha tocopherol acetate, dl-alpha tocopherolvitamin E, dl-pantothenyl alcohol, D-pantothenyl alcohol, pantotenylethyl Ethers, etc.) are also included in the oil-soluble vitamins used in the present invention. Oil-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification of microorganism culture, enzyme or chemical synthesis.

고분자 펩티드로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 콜라겐, 가수 분해 콜라겐, 젤라틴, 엘라스틴, 가수 분해 엘라스틴, 케라틴 등을 들 수 있다. 고분자 펩티드는 미생물의 배양액으로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 정제 취득할 수 있으며, 또는 통상 돼지나 소 등의 진피, 누에의 견섬유 등의 천연물로부터 정제하여 사용할 수 있다.The polymeric peptide may be any compound as long as it can be compounded in cosmetics, and examples thereof include collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, and keratin. Polymeric peptides can be purified and obtained by conventional methods such as purification from microbial cultures, enzymatic methods or chemical synthesis methods, or can be purified and used from natural products such as dermis and pig silk such as pigs and cattle.

고분자 다당으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 히드록시에틸셀룰로오스, 크산탄검, 히알루론산나트륨, 콘드로이틴 황산 또는 그 염 (나트륨염 등) 등을 들 수 있다. 예를 들어, 콘드로이틴 황산 또는 그 염 등은 통상 포유동물이나 어류로부터 정제하여 사용할 수 있다.The polymer polysaccharide may be any compound as long as it can be blended into cosmetics. Preferably, hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.) may be mentioned. For example, chondroitin sulfate or its salt, etc. can be normally purified from a mammal or fish.

스핑고 지질로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 세라미드, 피토스핑고신, 스핑고당지질 등을 들 수 있다. 스핑고 지질은 통상 포유류, 어류, 패류, 효모 또는 식물 등으로부터 통상의 방법에 의해 정제하거나 화학 합성법에 의해 취득할 수 있다.The sphingolipid may be any compound as long as it can be blended into cosmetics. Preferably, ceramide, phytosphingosine, sphingosaccharide lipid, etc. may be mentioned. Sphingo lipids can usually be purified from mammals, fish, shellfish, yeasts or plants by conventional methods or obtained by chemical synthesis.

해초 엑기스로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 갈조 엑기스, 홍조 엑기스, 녹조 엑기스 등을 들 수 있으며, 또, 이들의 해초 엑기스로부터 정제된 칼라기난, 아르긴산, 아르긴산나트륨, 아르긴산칼륨 등도 본 발명에서 사용되는 해초 엑기스에 포함된다. 해초 엑기스는 해초로부터 통상의 방법에 의해 정제하여 취득할 수 있다.The seaweed extract may be any compound as long as it can be blended into cosmetics. Preferably, the seaweed extract may include brown algae extract, red algae extract, green algae extract, and the like. Also, calginine, arginic acid, sodium arginate, Potassium arginate and the like are also included in the seaweed extract used in the present invention. Seaweed extract can be obtained by purification from seaweed by conventional methods.

본 발명의 화장료에는 상기 필수 성분과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합해도 된다.The cosmetic of the present invention may be blended with other essential ingredients, if necessary, in combination with the essential ingredients.

이외에 첨가해도 되는 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한(制汗)제, 정제수 등을 들 수 있다.Other components that may be added include fats and oils, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, ultraviolet absorbers, preservatives, fungicides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, flavorings, Blood circulation accelerators, cooling agents, restriction agents, purified water and the like.

유지 성분으로서는 에스테르계 유지, 탄화수소계 유지, 실리콘계 유지, 불소계 유지, 동물 유지, 식물 유지 등을 들 수 있다.Examples of the fat or oil component include ester fats, hydrocarbon fats, silicone fats, fluorine fats, animal fats, and vegetable fats and oils.

에스테르계 유지로서는 트리2-에틸헥산산글리세릴, 2-에틸헥산산세틸, 미리스틴산이소프로필, 미리스틴산부틸, 팔미틴산이소프로필, 스테아르산에틸, 팔미틴산옥틸, 이소스테아르산이소세틸, 스테아르산부틸, 리놀레산에틸, 리놀레산이소프로필, 올레인산에틸, 미리스틴산이소세틸, 미리스틴산이소스테아릴, 팔미틴산이소스테아릴, 미리스틴산옥틸도데실, 이소스테아르산이소세틸, 세바신산디에틸, 아디핀산디이소프로필, 네오펜탄산이소알킬, 트리(카프릴, 카프린산)글리세릴, 트리2-에틸헥산산트리메틸롤프로판, 트리이소스테아르산트리메틸롤프로판, 테트라2-에틸헥산산펜타엘리슬리톨, 카프릴산세틸, 라우린산데실, 라우린산헥실, 미리스틴산데실, 미리스틴산미리스틸, 미리스틴산세틸, 스테아르산스테아릴, 올레인산데실, 리시노올레인산세틸, 라우린산이소스테아릴, 미리스틴산이소트리데실, 팔미틴산이소세틸, 스테아르산옥틸, 스테아르산이소세틸, 올레인산이소데실, 올레인산옥틸도데실, 리놀레산옥틸도데실, 이소스테아르산이소프로필, 2-에틸헥산산세토스테아릴, 2-에틸헥산산스테아릴, 이소스테아르산헥실, 디옥탄산에틸렌글리콜, 디올레인산에틸렌글리콜, 디카프린산프로필렌글리콜, 디(카프릴,카프린산)프로필렌글리콜, 디카프릴산프로필렌글리콜, 디카프린산네오펜틸글리콜, 디옥탄산네오펜틸글리콜, 트리카프릴산글리세릴, 트리운데실산글리세릴, 트리이소팔미틴산글리세릴, 트리이소스테아르산글리세릴, 네오펜탄산옥틸도데실, 옥탄산이소스테아릴, 이소노난산옥틸, 네오데칸산헥실데실, 네오데칸산옥틸도데실, 이소스테아르산이소세틸, 이소스테아르산이소스테아릴, 이소스테아르산옥틸데실, 폴리글리세린올레인산에스테르, 폴리글리세린이소스테아르산에스테르, 시트르산트리이소세틸, 시트르산트리이소알킬, 시트르산트리이소옥틸, 락트산라우릴, 락트산미리스틸, 락트산세틸, 락트산옥틸데실, 시트르산트리에틸, 시트르산아세틸트리에틸, 시트르산아세틸트리부틸, 시트르산트리옥틸, 말산디이소스테아릴, 히드록시스테아르산 2-에틸헥실, 숙신산디2-에틸헥실, 아디핀산디이소부틸, 세바신산디이소프로필, 세바신산디옥틸, 스테아르산콜레스테릴, 이소스테아르산콜레스테릴, 히드록시스테아르산콜레스테릴, 올레인산콜레스테릴, 올레인산디히드로콜레스테릴, 이소스테아르산피트스테릴, 올레인산피트스테릴, 12-스테알로일히드록시스테아르산이소세틸, 12-스테알로일히드록시스테아르산스테아릴, 12-스테알로일히드록시스테아르산이소스테아릴 등의 에스테르계 등을 들 수 있다.As ester fats and oils, glyceryl tri2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl mystinate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, and stearic acid Butyl, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl acid isocetyl, isostyl acid isostearyl, isostaryl palmitate, octylate acid octyldodecyl, isostearic acid isetyl, diethyl sebacate, adipine Acid isopropyl, isoalkyl neopentane, tri (capryl, capric acid) glyceryl, trimethyl ethyl trimethylol propane, triisostearic acid trimethylol propane, tetra 2-ethylhexanoic penta erythritol Cetyl caprylate, lauric acid decyl, hexyl laurate, decyl myristin, myristin acid myristyl, myritic acid cetyl, stearyl stearate, decyl oleate, rininooleic acid , Isostearyl laurate, isotridecyl myristin, isocetyl palmitate, octyl stearate, isocetyl stearate, isodecate oleate, octylate decyl oleate, octyl dodecyl linoleate, isopropyl isopropyl acid, 2 -Cetostearyl ethylhexanoate, stearyl 2-ethylhexanoate, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicapric acid, propylene glycol dicacapate, capric acid Propylene glycol, dicapric acid neopentyl glycol, dioctanoate neopentyl glycol, tricaprylic acid glyceryl, triundecyl glyceryl, triisopalmitinate glyceryl, triisostearate glyceryl, neopentane dodecyl Isostearyl octanoate, octyl isononate, hexyl decyl neodecanoate, octyl dodecyl neodecanoate, isocetyl isostearate, isostearyl isostearate, Sothete octylate, polyglycerol oleate, polyglycerine isostearate, triisocetyl citrate, triisoalkyl citrate, triisoctyl citrate, lauryl lactate, myritic lactate, octyl lactate, octyl lactate, tricitric acid Ethyl, acetyl triethyl citrate, acetyl tributyl citrate, trioctyl citrate, diisostearyl malic acid, 2-ethylhexyl hydroxystearate, di2-ethylhexyl succinate, diisobutyl adipicate, diisopropyl sebacinate, Dioctyl sebacate, cholesteryl stearate, cholesteryl isostearate, cholesteryl hydroxystearate, cholesteryl oleate, dihydrocholesteryl oleate, physteryl isostearate, phytic oleate, 12-Steloylhydroxystearate isocetyl, 12-Steloylhydroxystearate stearyl, 12-stealo Esters such as monohydroxystearic acid isostearyl; and the like.

탄화 수소계 유지로서는 스쿠알렌, 유동 파라핀, 알파-올레핀올리고머, 이소파라핀, 세레신, 파라핀, 유동 이소파라핀, 폴리부덴, 마이크로크리스탈린왁스, 와셀린 등의 탄화 수소계 유지 등을 들 수 있다.Hydrocarbon-based fats and oils, such as squalene, a liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, a liquid isoparaffin, polybutene, microcrystal wax, and a vaseline, etc. are mentioned as a hydrocarbon-type fats and oils.

실리콘계 유지로서는 폴리메틸실리콘, 메틸페닐실리콘, 메틸시클로폴리실록산, 옥타메틸폴리실록산, 데카메틸폴리실록산, 도데카메틸시클로실록산, 디메틸실록산ㆍ메틸세틸옥시실록산 공중합체, 디메틸실록산ㆍ메틸스테알록시실록산 공중합체, 알킬 변성 실리콘유, 아미노 변성 실리콘유 등을 들 수 있다.Examples of the silicone-based oils and fats include polymethylsilicone, methylphenylsilicone, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane, methylcetyloxysiloxane copolymer, dimethylsiloxane and methylsteoxysiloxane copolymer, and alkyl. Modified silicone oil, amino modified silicone oil and the like.

불소계 유지로서는 퍼플루오로폴리에테르 등을 들 수 있다.Examples of the fluorine-based oil include perfluoropolyether and the like.

동물 또는 식물 유지로서는 아보카도유, 아르몬드유, 올리브유, 참깨유, 쌀겨유, 새플라워유, 대두유, 옥수수유, 유채유, 행인(杏仁)유, 팜핵유, 팜유, 피마자유, 해바라기유, 포도종자유, 면실유, 야자유, 쿠쿠이너트유, 소맥배아유, 쌀 배아유, 시아버터, 월견초유, 마커데이미아너트유, 메도홈유, 난황유, 우지(牛脂), 마유, 밍크유, 오렌지라피유, 호호바유, 캔데리러왁스, 카르나바왁스, 액상 라놀린, 경화피마자유 등의 동물 또는 식물 유지를 들 수 있다.Animal or vegetable oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, soybean oil, soybean oil, corn oil, rapeseed oil, almond oil, palm kernel oil, palm oil, castor oil, sunflower oil, grape seed oil. , Cottonseed oil, Palm oil, Cucumber nut oil, Wheat germ oil, Rice germ oil, Shea butter, Walnut colostrum oil, Marker demia nut oil, Meadow home oil, Egg yolk oil, Uji, Horse oil, Mink oil, Orange rape oil, Jojoba oil And animal or plant fats and oils such as candeler wax, carnava wax, liquid lanolin and hardened castor oil.

보습제로서는 수용성 저분자 보습제, 지용성 분자 보습제, 수용성 고분자, 지용성 고분자 등을 들 수 있다.Examples of the moisturizing agent include a water-soluble low molecular moisturizer, a fat-soluble molecular moisturizer, a water-soluble polymer, and a fat-soluble polymer.

수용성 저분자 보습제로서는 세린, 글루타민, 솔비톨, 만니톨, 피롤리돈-카르복실산나트륨, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜B(중합도 n = 2 이상), 폴리프로필렌글리콜(중합도 n = 2 이상), 폴리글리세린B(중합도 n = 2 이상), 락트산, 락트산염 등을 들 수 있다.Water-soluble low molecular humectants include serine, glutamine, sorbitol, mannitol, pyrrolidone-sodium carboxylate, glycerin, propylene glycol, 1,3-butylene glycol, ethylene glycol, polyethylene glycol B (polymerization degree n = 2 or more), polypropylene Glycol (polymerization degree n = 2 or more), polyglycerol B (polymerization degree n = 2 or more), lactic acid, lactic acid salt, etc. are mentioned.

지용성 저분자 보습제로서는 콜레스테롤, 콜레스테롤에스테르 등을 들 수 있다.Examples of the fat-soluble low molecular humectants include cholesterol and cholesterol esters.

수용성 고분자로서는 카르복시비닐폴리머, 폴리아스파라긴산염, 트라가칸트, 크산탄검, 메틸셀룰로오스, 히드록시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 카르복시메틸셀룰로오스, 수용성 키틴, 키토산, 덱스트린 등을 들 수 있다.Examples of the water-soluble polymer include carboxyvinyl polymer, polyasparaginate, tragacanth, xanthan gum, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, water soluble chitin, chitosan, and dextrin. Can be.

지용성 고분자로서는 폴리비닐피롤리돈ㆍ에이코센 공중합체, 폴리비닐피롤리돈ㆍ헥사데센 공중합체, 니트로셀룰로오스, 덱스트린지방산에스테르, 고분자 실리콘 등을 들 수 있다.Examples of the fat-soluble polymers include polyvinylpyrrolidone-eicosene copolymers, polyvinylpyrrolidone-hexadecene copolymers, nitrocellulose, dextrin fatty acid esters, polymer silicones, and the like.

에몰리엔트제로서는 장쇄아실글루타민산콜레스테릴에스테르, 히드록시스테아르산콜레스테릴, 12-히드록시스테아르산, 스테아르산, 로진산, 라놀린지방산콜레스테릴에스테르 등을 들 수 있다.Examples of the emollient include long-chain acyl glutamic acid cholesteryl esters, hydroxy stearic acid cholesterol, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl esters, and the like.

계면 활성제로서는 비이온성 계면 활성제, 음이온성 계면 활성제, 양이온성 계면 활성제, 양성 계면 활성제 등을 들 수 있다.As surfactant, nonionic surfactant, anionic surfactant, cationic surfactant, amphoteric surfactant, etc. are mentioned.

비이온성 계면 활성제로서는 자기 유화형 모노스테아르산글리세린, 프로필렌글리콜지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 솔비탄지방산에스테르, POE (폴리옥시에틸렌)솔비탄지방산에스테르, POE 솔비트지방산에스테르, POE 글리세린지방산에스테르, POE 알킬에테르, POE 지방산에스테르, POE 경화피마자유, POE 피마자유, POEㆍPOP (폴리옥시에틸렌ㆍ폴리옥시프로필렌) 공중합체, POEㆍPOP 알킬에테르, 폴리에테르변성실리콘, 라우린산알카놀아미드, 알킬아민옥시드, 수소첨가대두인지질 등을 들 수 있다.As the nonionic surfactant, self-emulsifying glycerin monostearate, propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerol fatty acid ester, sorbitan fatty acid ester, POE (polyoxyethylene) sorbitan fatty acid ester, POE sorbitan fatty acid ester, POE Glycerin fatty acid ester, POE alkyl ether, POE fatty acid ester, POE hardened castor oil, POE castor oil, POE / POP (polyoxyethylene / polyoxypropylene) copolymer, POE / POP alkyl ether, polyether modified silicone, lauric acid Alkanolamide, alkylamine oxide, hydrogenated soybean phospholipid, etc. are mentioned.

음이온성 계면 활성제로서는 지방산비누, 알파-아실술폰산염, 알킬술폰산염, 알킬알릴술폰산염, 알킬나프탈렌술폰산염, 알킬황산염, POE 알킬에테르황산염, 알킬아미드황산염, 알킬인산염, POE 알킬인삼염, 알킬아미드인산염, 알킬로일알킬타우린염, N-아실아미노산염, POE 알킬에테르카르복실산염, 알킬술포숙신산염, 알킬술포아세트산나트륨, 아실화 가수분해 콜라겐펩티드염, 퍼플루오로알킬인산에스테르 등을 들 수 있다.Anionic surfactants include fatty acid soaps, alpha-acyl sulfonates, alkyl sulfonates, alkyl allyl sulfonates, alkyl naphthalene sulfonates, alkyl sulfates, POE alkyl ether sulfates, alkylamide sulfates, alkyl phosphates, POE alkylphosphates, and alkylamides. Phosphates, alkyloylalkyltaurine salts, N-acylamino acid salts, POE alkyl ether carboxylate salts, alkyl sulfosuccinate salts, sodium alkyl sulfo acetates, acylated hydrolyzed collagen peptide salts, perfluoroalkyl phosphate esters, and the like. have.

양이온성 계면 활성제로서는 염화알킬트리메틸암모늄, 염화스테아릴트리메틸암모늄, 브롬화스테아릴트리메틸암모늄, 염화세토스테아릴트리메틸암모늄, 염화디스테아릴디메틸암모늄, 염화스테아릴디메틸벤질암모늄, 브롬화베헤닐트리메틸암모늄, 염화벤잘코늄, 스테아르산디에틸아미노에틸아미드, 스테아르산디메틸아미노프로필아미드, 라놀린 유도체 제 4급 암모늄염 등을 들 수 있다.As cationic surfactant, alkyl trimethylammonium chloride, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, cetostearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, stearyl dimethyl benzyl ammonium bromide, behenyl trimethyl ammonium chloride, chloride Benzalkonium, diethylaminoethyl stearate, dimethylaminopropyl stearate, lanolin derivatives, quaternary ammonium salts, and the like.

양성 계면 활성제로서는 카르복시베타인형, 아미드베타인형, 술포베타인형, 히드록시술포베타인형, 아미드술포베타인형, 포스포베타인형, 아미노카르복실산염형, 이미다졸린 유도체형, 아미드아민형 등의 양성 계면 활성제 등을 들 수 있다.Examples of amphoteric surfactants include the carboxybetaine type, the amide betain type, the sulfobetain type, the hydroxysulfobetain type, the amide sulfobetain type, the phosphobetaine type, the aminocarboxylate type, the imidazoline derivative type, and the amideamine type. An amphoteric surfactant etc. are mentioned.

유기 및 무기 안료로서는 규산, 무수규산, 규산마그네슘, 탤크, 세리사이트, 마이카, 카올린, 벵갈라, 클레이, 벤토나이트, 티탄피막운모, 옥시염화비스무트, 산화지르코늄, 산화마그네슘, 산화아연, 산화티탄, 산화알루미늄, 황산칼슘, 황산바륨, 황산마그네슘, 탄산칼슘, 탄산마그네슘, 산화철, 군청, 산화크롬, 수산화크롬, 칼라민 및 이들의 복합체등의 무기 안료 ; 폴리아미드, 폴리에스테르, 폴리프로필렌, 폴리스티렌, 폴리우레탄, 비닐수지, 요소수지, 페놀수지, 불소수지, 규소수지, 아크릴수지, 멜라민수지, 에폭시수지, 폴리카보네이트수지, 디비닐벤젠ㆍ스티렌 공중합체, 실크파우더, 셀룰로오스, CI 피그먼트옐로우, CI 피그먼트오렌지 등의 유기 안료 및 이들의 무기 안료와 유기 안료의 복합 안료 등을 들 수 있다.Examples of the organic and inorganic pigments include inorganic pigments such as silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, Bengala, clay, bentonite, titanium mica, titanium oxide, bismuth chloride, zirconium oxide, magnesium oxide, Inorganic pigments such as calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, chromium oxide, chromium oxide, chromium hydroxide, Polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluorine resin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene, styrene copolymer, Organic pigments such as silk powder, cellulose, CI pigment yellow, CI pigment orange, and composite pigments of these inorganic pigments and organic pigments;

유기 분체로서는 스테아르산칼슘 등의 금속비누 ; 세틸린산아연나트륨, 라우릴린산아연, 라우릴린산칼슘 등의 알킬인산금속염 ; N-라우로일-베타-알라닌칼슘, N-라우로일-베타-알라닌아연, N-라우로일글리신칼슘 등의 아실아미노산 다가금속염 ; N-라우로일-타우린칼슘, N-팔미토일-타우린칼슘 등의 아미드술폰산 다가금속염 ; N-엡실론-라우로일-L-리진, N-엡실론-팔미토일리진, N-알파-파리토일올니틴, N-알파-라우로일아르기닌, N-알파-경화우지지방산아실아르기닌 등의 N-아실염기성아미노산 ; N-라우로일글리실글리신 등의 N-아실폴리펩티드 ; 알파-아미노카프릴산, 알파-아미노라우린산 등의 알파-아미노지방산 ; 폴리에틸렌, 폴리프로필렌, 나일론, 폴리메틸메타크릴레이트, 폴리스티렌, 디비닐벤젠ㆍ스티렌 공중합체, 사불화에틸렌 등을 들 수 있다.As organic powder, Metal soaps, such as a calcium stearate; Alkyl phosphate metal salts such as sodium cetylinate, zinc lauryl acid and calcium laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc, and N-lauroylglycine calcium; Amide sulfonic acid polyvalent metal salts, such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; N-epsilon-lauroyl-L-lysine, N-epsilon-palmitolyzine, N-alpha-paratoylol nitin, N-alpha-lauroyl arginine, N-alpha-cured fatty acid acyl arginine -Acyl basic amino acid; N-acyl polypeptides, such as N-lauroyl glycyl glycine; Alpha-amino fatty acids such as alpha-aminocaprylic acid and alpha-aminolauric acid; Polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene-styrene copolymer, ethylene tetrafluoride and the like.

자외선 흡수제로서는 파라아미노벤조산, 파라아미노벤조산에틸, 파라아미노벤조산아밀, 파라아미노벤조산옥틸, 살리실산에틸렌글리콜, 살리신산페닐, 살리신산옥틸, 살리신산벤질, 살리신산부틸페닐, 살리신산호모멘틸, 계피산벤질, 파라메톡시계피산-2-에톡시에틸, 파라메톡시계피산옥틸, 디파라메톡시계피산모노-2-에틸헥산글리세릴, 파라메톡시계피산이소프로필, 디이소프로필ㆍ디이소프로필계피산에스테르 혼합물, 우로카닌산, 우로카닌산에틸, 히드록시메톡시벤조페논, 히드록시메톡시벤조페논술폰산 및 그 염, 디히드록시메톡시벤조페논, 디히드록시메톡시벤조페논디술폰산나트륨, 디히드록시벤조페논, 테트라히드록시벤조페논, 4-tert-부틸-4'-메톡시디벤조일메탄, 2,4,6-트리아닐리노-p-(카르보-2'-에틸헥실-1'-옥시)-1,3,5-트리아진, 2-(2-히드록시-5-메틸페닐)벤조트리아졸 등을 들 수 있다.Examples of the ultraviolet absorber include paraaminobenzoic acid, ethyl paraaminobenzoate, amyl paraaminobenzoic acid, octyl paraaminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomentyl salicylic acid and benzyl cinnamic acid. , Paramethoxy cinnamic acid-2-ethoxyethyl, paramethoxy cinnamic acid octyl, diparamethoxy cinnamic acid mono-2-ethylhexaneglyceryl, paramethoxy cinnamic acid isopropyl, diisopropyl diisopropyl cinnamic acid ester mixture, wuro Canonic acid, ethyl urokanoate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenonesulfonic acid and salts thereof, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenone sodium sulfonate, dihydroxybenzophenone , Tetrahydroxybenzophenone, 4- tert -butyl-4'-methoxydibenzoylmethane, 2,4,6-trianilino- p- (carbo-2'-ethylhexyl-1'-oxy) -1 , 3,5-triazine, 2- (2-hi And the like can be mentioned hydroxy-5-methylphenyl) benzotriazole.

살균제로서는 히노키티올, 트리클로산, 트리클로로히드록시디페닐에테르, 크로르헥시딘글루콘산염, 페녹시에탄올, 레조르신, 이소프로필메틸페놀, 아줄렌, 살리칠산, 진크필리티온, 염화벤잘코늄, 감광소 301호, 모노니트로과이어콜나트륨, 운데시렌산 등을 들 수 있다.Examples of the disinfectant include hinokitiol, trichloroacid, trichlorohydroxydiphenyl ether, crohexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, zinc filitione, benzalkonium chloride, No. 301, mononitro and eicol sodium, and undecylenic acid.

산화 방지제로서는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 들 수 있다.Examples of the antioxidant include butylhydroxyanisole, propyl gallic acid, and erythorbic acid.

pH 조정제로서는 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 들 수 있다.Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fmaric acid, sodium pmarate, succinic acid, sodium succinate, sodium hydroxide, sodium dihydrogen phosphate, and the like.

알코올로서는 세틸알코올 등의 고급 알코올을 들 수 있다.Examples of the alcohol include higher alcohols such as cetyl alcohol.

또한, 이외에 첨가해도 되는 배합 성분은 이에 한정되는 것은 아니며, 또, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하지만, 총중량에 대하여 바람직하게는 0.01 - 5 % 중량, 보다 바람직하게는 0.01 - 3 % 중량으로 배합된다.In addition, the compounding component which may be added other than this is not limited to this, Moreover, Although all said components can be mix | blended within the range which does not impair the objective and effect of this invention, Preferably it is 0.01-5% weight with respect to gross weight, More Preferably 0.01-3% by weight.

본 발명의 화장료는 용액, 유화물, 점성형 혼합물 등의 형상을 취할 수 있다.The cosmetic of the present invention may take the form of a solution, an emulsion, a viscous mixture or the like.

본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 복합생약 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다.Components included in the cosmetic composition of the present invention may include components commonly used in cosmetic compositions in addition to the complex herbal extract as an active ingredient, for example, such as stabilizers, solubilizers, vitamins, pigments and flavorings Phosphorus aids and carriers.

본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 유액, 크림, 화장수, 팩, 파운데이션, 로션, 미용액, 모발화장료 등을 들 수 있다.The cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, and includes, for example, milky lotion, cream, lotion, pack, foundation, lotion, essence, hair cosmetic, and the like.

구체적으로, 본 발명의 화장료 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저의 제형을 포함한다.Specifically, the cosmetic composition of the present invention can be used as a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, a nutrition cream, a moisturizing cream, a hand cream, Packs, soaps, cleansing foams, cleansing lotions, cleansing creams, body lotions and body cleansers.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.In the case where the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. Especially, in the case of a spray, a mixture of chlorofluorohydrocarbons, propane / Propane or dimethyl ether.

본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.In the case of the solution or emulsion of the present invention, a solvent, a solvent or an emulsifier is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.

본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다. When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolenic derivatives or ethoxylated glycerol fatty acid esters.

본 발명의 복합생약 추출물은 우수한 티로시나제 저해활성을 나타내며 B16F10 melanoma 세포를 이용한 실험에서 우수한 멜라닌 합성 저해 활성을 나타내는바 피부미백용 조성물로 유용하게 이용될 수 있다.Complex herbal extract of the present invention shows excellent tyrosinase inhibitory activity and shows excellent melanin synthesis inhibitory activity in experiments using B16F10 melanoma cells can be usefully used as a composition for skin whitening.

도 1은 복합생약 추출물을 처리한 B16F10 melanoma 세포의 세포 생존력을 나타낸 도이고,
도 2는 복합생약 추출물이 가지는 멜라닌 생성 억제 효과를 나타내는 도이고,
도 3은 복합생약 추출물 첨가에 따른 티로시나제 활성 억제 효과를 나타낸 도이고,
도 4는 복합생약 70% 에탄올 추출물 처리 후 티로시나제 단백질과 TRP-1 발현을 나타낸 도이며,
도 5는 복합생약 물 추출물 처리 후 티로시나제 단백질과 TRP-1 발현을 나타낸 도이다.
1 is a diagram showing the cell viability of B16F10 melanoma cells treated with the extract of the herbal medicine,
2 is a diagram showing the melanin production inhibitory effect of the complex herbal extracts,
Figure 3 is a diagram showing the effect of inhibiting tyrosinase activity according to the addition of the compound herbal extract,
Figure 4 is a diagram showing the expression of tyrosinase protein and TRP-1 after treatment with 70% ethanol extract of the compound,
Figure 5 is a diagram showing the expression of tyrosinase protein and TRP-1 after treatment with the herbal extract extract.

이하, 본 발명을 하기의 실시예 및 실험예에 의해 상세히 설명한다.Below, The invention is illustrated in detail by the following examples and experimental examples.

단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.
However, the following examples and experimental examples are illustrative of the present invention, and the content of the present invention is not limited by the following examples and experimental examples.

실시예 1. 복합생약 물 추출물의 제조Example 1 Preparation of a Complex Herbal Water Extract

복합생약 물 추출물의 제조에 필요한 구성약재는 (주) 휴먼허브에서 구입하여 사용하였다. 시료는 대황 30g, 계지 20g, 망초 20g, 감초 100g, 도인 100g을 혼합하여 준비하여 증류수 10배의 양을 가하여 85℃에서 3시간 환류냉각 추출하여 상등액과 침전물을 분리하여 3회 반복 추출하여, 복합생약 물 추출물(이하, “DO-W”라 함) 51.12g을 얻은 후, Whatman No.1 여과지로 여과하고 농축하여 동결건조 후 냉장실에 보관하면서 본 실험의 시료로 사용하였다.
Ingredients necessary for the preparation of the complex herbal extracts were purchased from Human Hub Co., Ltd. Samples were prepared by mixing 30g rhubarb, 20g gage, 20g nettle, 100g licorice and 100g phosphorus, adding 10 times the amount of distilled water, extracting by reflux cooling at 85 ° C for 3 hours, separating supernatant and sediment three times, and extracting them repeatedly. 51.12 g of herbal extract (hereinafter referred to as “DO-W”) was obtained, filtered through Whatman No. 1 filter paper, concentrated, freeze-dried and stored in a refrigerator to use as a sample of this experiment.

실시예 2. 복합생약 에탄올 추출물의 제조Example 2. Preparation of Complex Herbal Ethanol Extract

복합생약 에탄올 추출물의 제조에 필요한 구성약재는 (주) 휴먼허브에서 구입하여 사용하였다. 시료는 대황 30g, 계지 20g, 망초 20g, 감초 100g, 도인 100g을 혼합하여 준비하여, 10배 양의 70% 에탄올을 첨가하여 실온에서 24시간 동안 침지추출한 후 상등액과 침전물을 분리하는 방법으로 3회 반복 추출하여 복합생약 70% 에탄올 추출물(이하, “DO-EtOH”라 함) 19.58g 을 얻은 후, Whatman No.1 여과지로 여과하고 농축하여 동결건조 후 냉장실에 보관하면서 본 실험의 시료로 사용하였다.
Constituents necessary for the preparation of the compound herbal ethanol extract were purchased from Human Hub Co., Ltd. Samples were prepared by mixing 30g rhubarb, 20g gage, 20g nettle, 100g licorice and 100g phosphorus, and immersion extraction at room temperature for 24 hours by adding 70% ethanol in 10 times and separating supernatant and precipitate three times. After repeated extraction, 19.58 g of a compound herbal 70% ethanol extract (hereinafter referred to as “DO-EtOH”) was obtained, filtered through Whatman No. 1 filter paper, concentrated, lyophilized, and stored as a sample in the refrigerator. .

참고예 1. 세포 배양Reference Example 1. Cell Culture

B16F10 melanoma 세포는 Michikawa(Michikawa, M., K.T. Lim, J. G. McLarnon and S. U. Kim. 1994. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci Res. 37, 62-70.)등의 방법에 따라 배양 세포에 0.25% 트립신(trypsin) 용액을 희석 처리한 후 세포를 분리한 다음 Dulbeco's modified eagle’s medium (DMEM) 배지에 10% fetal bovine serum (FBS)과 1% 페니실린/스트렙토마이신(penicillin/streptomycin) (100U/ml)을 첨가하여 37℃, 5% CO2 incubator에 적응시켜 배양하였다.
B16F10 melanoma cells according to the method of Michikawa (Michikawa, M., KT Lim, JG McLarnon and SU Kim. 1994. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci Res. 37, 62-70.) After diluting the 0.25% trypsin solution in the cultured cells, the cells were isolated, and then, in Dulbeco's modified eagle's medium (DMEM) medium, 10% fetal bovine serum (FBS) and 1% penicillin / streptomycin (penicillin / streptomycin) ( 100U / ml) was added and incubated in a 37 ° C., 5% CO 2 incubator.

실험예 1. MTT assay에 의한 세포 생존능력 측정Experimental Example 1. Measurement of cell viability by MTT assay

세포 생존률 측정은 Carmichael 등의 방법에 따라 측정하였다(Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosen- sitivity testing. Cancer Res . 47, 936-942.). Melanoma (B16F10)을 96 well plate에 0.6~0.8×103cells/well이 되게 0.18ml 분주하고, 시료를 농도 별로 조제하여 0.02ml 첨가한 후 37℃, 5% CO2 incubator에서 24시간 배양하였다. 대조군은 시료와 동량의 증류수를 첨가하여 동일한 조건으로 배양하였다. 여기에 5mg/ml 농도로 제조한 MTT 용액 0.02ml를 첨가하여 4시간 배양한 후 배양액을 제거하고 각 well당 DMSO:EtOH (1:1) 0.15ml를 가하여 실온에서 30분간 반응 시킨 뒤 ELISA reader로 550nm에서 흡광도를 측정하였다. 세포 독성 측정은 하기 수학식 1과 같이 시료용액의 첨가군와 무첨가군의 흡광도 감소율로 나타내었다.Cell viability was measured according to a method such as Carmichael (Carmichael, J., DeGraff WG, Gazdar AF, Minna JD, Mitchell JB and 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay:.. Assessment of chemosen- sitivity testing Cancer Res . 47 , 936-942.). Melanoma (B16F10) was dispensed 0.18ml in a 96 well plate at 0.6 ~ 0.8 × 10 3 cells / well. Samples were prepared for each concentration, added 0.02ml, and incubated in 37 ° C. and 5% CO 2 incubator for 24 hours. In the control group, the same amount of distilled water as that of the sample was added and the cells were cultured under the same conditions. After incubation for 4 hours with the addition of 0.02ml of MTT solution prepared at 5mg / ml concentration, the culture medium was removed, and 0.15ml of DMSO: EtOH (1: 1) was added to each well, followed by reaction at room temperature for 30 minutes, followed by ELISA reader. Absorbance was measured at 550 nm. Cytotoxicity measurement was expressed as the absorbance reduction rate of the sample solution addition group and no addition group, as shown in Equation 1 below.

Figure 112010061928382-pat00001
Figure 112010061928382-pat00001

복합생약 추출물의 B16F10 melanoma 세포의 증식에 미치는 영향을 알아보기 위하여 복합생약 70% 에탄올 추출물과 물 추출물을 10, 25, 50, 75, 100, 250 μg/ml 농도를 처리하고 48시간 후에 MTT방법으로 세포의 증식을 관찰하였다. 그 결과 대조군의 세포 증식율을 100%로 하였을 때 250 μg/ml 이하 농도에서는 독성이 관찰되지 않았다(도 1 참조).
In order to investigate the effects of the combined herbal extracts on the proliferation of B16F10 melanoma cells, the mixed herbal 70% ethanol extract and water extract were treated with 10, 25, 50, 75, 100, 250 μg / ml concentration and 48 hours after The proliferation of the cells was observed. As a result, toxicity was not observed at concentrations of 250 μg / ml or less when the cell proliferation rate of the control group was 100% (see FIG. 1).

실험예 2. 멜라닌 측정Experimental Example 2 melanin measurement

멜라닌 양은 Hosoi등의 방법을 변형하여 사용하였다(Hosoi, J., et al. 1985. Regulation of melanin synthesis of B16 melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. J. cancer. Res. 45, 1474-1478.). 세포를 배양하여 PBS로 2회 세척한 후 원심분리하여 세포 침전물을 만들었다. 10% DMSO가 첨가된 1N NaOH 용액을 150 μl 첨가하고 60℃에서 1시간 용해하였으며 405nm에서 흡광도를 측정하였다. 멜라닌 양은 합성 멜라닌을 사용하여 작성된 표준 직선에서 구하고 실험군의 멜라닌 양은 대조군의 멜라닌 양에 대한 백분율로 계산하여 나타내었다. The amount of melanin was modified by Hosoi et al. (Hosoi, J., et al. 1985. Regulation of melanin synthesis of B16 melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.J. cancer.Res. 45, 1474-1478.). Cells were cultured, washed twice with PBS, and then centrifuged to form cell precipitates. 150 μl of a 1N NaOH solution added with 10% DMSO was added and dissolved for 1 hour at 60 ° C., and the absorbance was measured at 405 nm. The melanin amount was obtained from a standard straight line prepared using synthetic melanin, and the melanin amount of the experimental group was expressed as a percentage of the melanin amount of the control group.

복합생약 추출물이 가지는 멜라닌 생성 억제 효과를 측정한 결과 (도 2 참조) 농도 의존적으로 저해됨을 관찰할 수 있었다. 그리고 α-MSH와 시료를 동시에 처리한 실험군에서는 α-MSH만 처리한 대조군에 비해 저해되고 있음을 관찰하였다. 이는 α-MSH에 의해 유도된 멜라닌 생합성 신호전달 경로에 복합생약이 작용하고 있음을 말해주는 결과이다. 또한 물 추출물 보다 70% 에탄올 추출물이 활성이 우수하였다. 티로시나제(Tyrosinase) 활성 측정 결과와 마찬가지로 농도 의존적으로 멜라닌 생성을 억제 시켜주는 역할을 하고 있음을 관찰할 수 있었다. 미백 화장품에서 미백 원료로 쓰이는 아르부틴(Arbutin) 보다 우수한 활성을 보여 복합생약 추출물은 천연 미백 화장품 소재로써 우수한 소재임을 확인 하였다.
As a result of measuring the melanin production inhibitory effect of the complex herbal extract (see Fig. 2) it could be observed that the concentration-dependent inhibition. In addition, it was observed that the experimental group treated with α-MSH and the sample at the same time was inhibited compared to the control treated with α-MSH alone. This suggests that the combination drug acts on melanin biosynthetic signaling pathway induced by α-MSH. In addition, 70% ethanol extract was superior to water extract. As with the results of Tyrosinase activity measurement, it was observed that it plays a role in inhibiting melanin production in a concentration-dependent manner. It was confirmed that the compound herbal extract is an excellent material as a natural whitening cosmetic material by showing superior activity than Arbutin, which is used as a whitening ingredient in whitening cosmetics.

실험예 3. Tyrosinase 활성 측정Experimental Example 3. Measurement of Tyrosinase Activity

티로시나제(Tyrosinase) 활성 측정은 Choi5 등의 방법을 변형하여 측정하였다(Choi, B.W., et al. 1998. Screening of the tyrosinase inhibitors from marine algae and medicinal plants. Kor J Pharmacogn. 29. 237-242.). 각 well의 세포에 lysis buffer(1% triton X-100, 0.1M Sodium phosphate buffer, 50mM PMSF, pH 6.8)를 가하였다. 얼음 위에서 세포를 파괴시키고 원심분리한 후 상층액만 따로 모아 효소용액으로 사용하였다. L-DOPA를 2 mg/ml 농도로 0.1M Sodium phosphate buffer(pH 6.8)에 녹여 기질을 준비하고 기질 160 μl에 효소용액 40 μl를 가하고 37℃에서 1시간 가온하고 생성된 DOPA chrome의 양을 490nm에서 측정하였다. 저해율은 하기 수학식 2와 같이 나타내었다.Tyrosinase activity was measured by a modification of Choi5 et al. (Choi, B.W., et al. 1998. Screening of the tyrosinase inhibitors from marine algae and medicinal plants.Kor J Pharmacogn. 29. 237-242.). Lysis buffer (1% triton X-100, 0.1M Sodium phosphate buffer, 50mM PMSF, pH 6.8) was added to the cells of each well. After the cells were destroyed on ice and centrifuged, only the supernatant was collected and used as an enzyme solution. Prepare the substrate by dissolving L-DOPA in 0.1M Sodium phosphate buffer (pH 6.8) at 2 mg / ml concentration, add 40 μl of enzyme solution to 160 μl of substrate, warm at 37 ℃ for 1 hour, and produce 490nm. Measured at The inhibition rate is expressed as in Equation 2 below.

Figure 112010061928382-pat00002
Figure 112010061928382-pat00002

복합생약 추출물 첨가에 따른 티로시나제(tyrosinase) 활성 측정 결과, 시료의 처리 농도가 높아질수록 티로시나제(tyrosinase) 활성이 억제됨을 확인할 수 있었다(도 3 참조). 복합생약 70% 에탄올 추출물 100 μg/ml에서 57%의 활성 억제가 관찰되었지만 물 추출물은 70% 에탄올 추출물과 같은 농도에서 우수한 활성이 확인되지 않았다. Lee, Y. H., et al. 2006. Whitening effect of mycelial cuture broth of paecilomyces japonica in the mixture of cucumber and grape extracts. J Life Science 16, 870-875. 등의 연구 결과에 따르면 시료 10% 첨가 시 50%의 티로시나제(tyrosinase)의 활성이 억제되는 것을 보았을 때 복합생약 70% 에탄올 추출물의 티로시나제(tyrosinase) 활성 억제능이 우수함을 알 수 있다. 티로시나제(Tyrosinase)의 작용은 멜라노솜(melanosome)에서 멜라닌이 생성되게 하는 효소로써 피부노화 촉진 및 색소 침착 등의 문제를 야기시킬 수 있다(Tomohiro, I. et al. 2005 Hot water extracts from Adzuki Beans(vigna angularis) stimulate not only melanogensis in cultured mouse B16 melanoma cells but also pigmentation of hair color in C3H mice. BioSci. Biotechnol. Biochem. 69, 873-882.). 따라서 복합생약 추출물은 티로시나제(tyrosinase) 활성을 억제시킴으로서 미백화장품 소재로 이용 가능하리라 사료되었다.
As a result of measuring tyrosinase activity according to the addition of the complex herbal extract, it was confirmed that tyrosinase activity was inhibited as the treatment concentration of the sample was increased (see FIG. 3). Inhibition of 57% activity was observed at 100 μg / ml of the combined herbal 70% ethanol extract, but the water extract did not show good activity at the same concentration as the 70% ethanol extract. Lee, YH, et al. 2006.Whitening effect of mycelial cuture broth of paecilomyces japonica in the mixture of cucumber and grape extracts. J Life Science 16, 870-875. According to the results of the study, it can be seen that the inhibitory activity of tyrosinase activity of the 70% ethanol extract of the compound herbal 70% thyrosinase activity when the addition of 10% of the sample is inhibited. The action of tyrosinase is an enzyme that causes melanin production in melanosomes, which can cause problems such as skin aging and pigmentation (Tomohiro, I. et al. 2005 Hot water extracts from Adzuki Beans ( vigna angularis) stimulate not only melanogensis in cultured mouse B16 melanoma cells but also pigmentation of hair color in C3H mice.BioSci. Biotechnol. Biochem. 69, 873-882.). Therefore, the herbal extracts may be used as whitening cosmetics by inhibiting tyrosinase activity.

실험예Experimental Example 4.  4. WesternWestern blotblot 을 통한 미백 관련 단백질의 발현 측정 Expression of whitening-related proteins

B16F10 melanoma 세포를 60mm tissue culture dish에 2×104cells/well에 되도록 분주하고 24시간 동안 배양하였다. 배지를 제거한 후 복합생약 추출물을 농도별로 처리한 배지로 교환하고 48시간 배양한 후 PBS로 세척하였다. Lysis buffer 100ul를 첨가하여 세포를 용해시키고 원심분리 하여(12,000rpm, 4℃, 20min) 세포막 성분들을 제거하였다. 원심 분리하여 얻은 단백질은 bradford assay로 정량하였으며, 60ul의 단백질을 10%의 SDS-PAGE를 이용하여 전기 영동한 후, 항체의 비특이적 결합을 억제시키기 위해 PVDF membrane에 옮긴 다음 30~40V에서 2시간 이상 transfer하였다. Transfer가 끝나면 ponceau에 담근 후 band를 확인하고 TBST로 2회 이상 씻은 후 꺼내서 5% skim milk로 overnight시켜 background는 제거시켰다. 3회 washing 후 1차 antibody (1:1000)를 1시간 동안 붙인 후 다시 2차 antibody (1:1000)를 붙이고 ECLkit (Milipore, Germany)를 이용하여 film에 옮겨 측정하였다. Band density는 Gel doc (Amersham Pharmacia, England)으로 확인하였다.B16F10 melanoma cells were aliquoted to 2 × 10 4 cells / well in a 60 mm tissue culture dish and incubated for 24 hours. After removing the medium, the complex herbal extracts were replaced with the concentration-treated medium, incubated for 48 hours, and washed with PBS. Lysis buffer 100ul was added to lyse the cells and centrifuged (12,000rpm, 4 ℃, 20min) to remove the cell membrane components. The protein obtained by centrifugation was quantified by bradford assay, 60ul of protein was electrophoresed using 10% SDS-PAGE, and then transferred to PVDF membrane to inhibit the nonspecific binding of the antibody and then at 30 ~ 40V for 2 hours or more. transferred. After transfer, soak in ponceau, check band, wash twice with TBST, take out, overnight with 5% skim milk and remove background. After washing three times, the primary antibody (1: 1000) was attached for 1 hour, and then the secondary antibody (1: 1000) was attached again, and transferred to a film using ECLkit (Milipore, Germany). Band density was confirmed by Gel doc (Amersham Pharmacia, England).

복합생약 추출물의 티로시나제(tyrosinase) 활성 및 멜라닌 생합성이 저해에 우수한 소재임을 확인하고 멜라닌 생합성 관련 단백질의 발현 양상을 분석한 결과, B16F10 melanoma 세포에 복합생약 70% 에탄올 추출물(도 4 참조), 물 추출물(도 5 참조)을 각각 50, 75 100 μg/ml 처리한 후 48시간 뒤에 티로시나제 단백질(tyroinase protein)과 TRP-1 발현을 wastern blotting으로 확인하였다. 이 때 세포의 여러 조건에서도 그 발현정도의 차이가 거의 없는 항존유전자(house keeping gene)인 β-actin을 positive control로 사용하였다. 이에 복합생약 추출물은 티로시나제(Tyrosinase)와 TRP-1(DHICA Oxidase)의 발현을 농도 의존적으로 저해하는 결과를 관찰하였다. 복합생약 70% 에탄올 추출물의 경우 티로시나제(Tyrosinase) 단백질은 100 μg/ml에서 50%의 저해효과를 관찰할 수 있었다. TRP-1은 대조군에 비해 저해가 거의 없음을 확인할 수 있었다. 복합생약의 물 추출물의 경우 티로시나제(Tyrosinase) 저해율이 100 μg/ml에서 우수하였고 TRP-1 저해율은 70% 에탄올 추출물보다 나은 효과를 관찰할 수 있었다. 티로시나제(Tyrosinase)와 TRP-1의 발현 저해는 α-MSH에 의한 세포신호전달 경로 중 지속적인 ERK 활성화를 저해함으로써 멜라닌 생합성에 직접적으로 관여하는 효소인 티로시나제(Tyrosinase)와 TRP-1의 발현을 저해하는 것으로 사료된다.
Tyrosinase activity and melanin biosynthesis of the multi-drug extracts were confirmed to be excellent materials for inhibition and analysis of the expression patterns of melanin biosynthesis-related proteins. 70-% ethanol extract of the multi-drugs on B16F10 melanoma cells (see Figure 4), water extract (See FIG. 5) After treating 50 and 75 100 μg / ml, 48 hours later, tyrosinase protein and TRP-1 expression were confirmed by wastern blotting. At this time, β-actin, a house keeping gene, which has little difference in expression level even under various conditions of cells, was used as a positive control. Thus, the herbal extracts were observed to inhibit the expression of tyrosinase (Tyrosinase) and TRP-1 (DHICA Oxidase) in a concentration-dependent manner. In the case of the 70% ethanol extract, the tyrosinase protein showed 50% inhibitory effect at 100 μg / ml. TRP-1 was confirmed that little inhibition compared to the control. In the case of water extract of the combined herbal, tyrosinase inhibition was excellent at 100 μg / ml and TRP-1 inhibition was better than 70% ethanol extract. Inhibition of expression of tyrosinase and TRP-1 inhibits the expression of tyrosinase and TRP-1, enzymes directly involved in melanin biosynthesis by inhibiting continuous ERK activation in the cell signaling pathway by α-MSH. It is considered to be.

이하, 본 발명의 제형예로서 크림, 맛사지크림, 로션, 스킨로션, 에센스, 팩, 클렌징폼의 제형을 예시하고 있으나, 본 발명의 화장품 조성물을 포함하는 제형은 이에 한정되는 것은 아니다.
Hereinafter, the formulation of the present invention is exemplified as a cream, massage cream, lotion, skin lotion, essence, packs, cleansing foam formulation, but is not limited to the formulation comprising the cosmetic composition of the present invention.

제형예Formulation Example 1. 크림조성물 1. Cream composition

유상과 수상을 각각 75℃로 가열 혼합한 후 실온으로 냉각한다.The oil phase and the water phase are heated and mixed at 75 ° C., respectively, and then cooled to room temperature.

Figure 112010061928382-pat00003
Figure 112010061928382-pat00003

제형예Formulation Example 2.  2. 맛사지크림Massage cream 조성물 Composition

유상과 수상을 각각 75℃로 가열 용해 혼합한 후 실온으로 냉각한다.The oil phase and the water phase are each dissolved by heating at 75 ° C., and then cooled to room temperature.

Figure 112010061928382-pat00004
Figure 112010061928382-pat00004

제형예Formulation Example 3. 로션 조성물 3. Lotion Composition

유상과 수상을 각각 75℃로 가열 혼합 유화한 후 실온으로 냉각한다.The oil phase and the water phase are heated, mixed and emulsified at 75 ° C., respectively, and cooled to room temperature.

Figure 112010061928382-pat00005
Figure 112010061928382-pat00005

제형예Formulation Example 4. 스킨로션 조성물 4. Skin Lotion Composition

수상과 에탄올상을 각각 제조 혼합한 후 여과한다.The aqueous phase and the ethanol phase are each prepared, mixed and filtered.

Figure 112010061928382-pat00006
Figure 112010061928382-pat00006

제형예Formulation Example 5. 에센스 조성물 5. Essence Composition

수상과 에탄올상을 각각 제조 혼합한 후 여과한다.The aqueous phase and the ethanol phase are each prepared, mixed and filtered.

Figure 112010061928382-pat00007
Figure 112010061928382-pat00007

제형예Formulation Example 6. 팩 조성물 6. Pack Composition

수상과 에탄올상을 각각 분산 용해하여 혼합시킨 후 실온으로 냉각한다.The aqueous and ethanol phases are dispersed, dissolved and mixed, and then cooled to room temperature.

Figure 112010061928382-pat00008
Figure 112010061928382-pat00008

제형예Formulation Example 7.  7. 클렌징폼Cleansing Foam 조성물 Composition

수상과 오일상을 각각 분산 용해하여 혼합 검화한 후 실온으로 냉각한다.The aqueous and oil phases are dispersed, dissolved and mixed, and then cooled and cooled to room temperature.

Figure 112010061928382-pat00009

Figure 112010061928382-pat00009

Claims (7)

삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 대황, 계지, 감초, 도인 및 망초의 건조 혼합중량비(%)가 1~9 : 1~6 : 1~6 : 1~30 : 1~30로 구성된 복합생약의 물 및 에탄올 용매 추출물을 유효성분으로 함유하는 미백용 화장료 조성물.The dry and mixed weight ratio (%) of rhubarb, gyeji, licorice, cabbage and mango are 1 ~ 9: 1 ~ 6: 1 ~ 6: 1 ~ 30: 1 ~ 30 water and ethanol solvent extract as an active ingredient Cosmetic composition for whitening containing. 제 6항에 있어서 상기 화장료 조성물은 화장수, 스킨, 로션, 영양로션, 영양크림, 마사지 크림, 에센스, 팩의 제형인 것을 특징으로 하는 화장료 조성물.
7. The cosmetic composition according to claim 6, wherein the cosmetic composition is in the form of a lotion, skin, lotion, nutrition lotion, nutrition cream, massage cream, essence, pack.
KR1020100093236A 2010-09-27 2010-09-27 Skin whitening composition comprising complex herbal extract KR101238963B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100093236A KR101238963B1 (en) 2010-09-27 2010-09-27 Skin whitening composition comprising complex herbal extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100093236A KR101238963B1 (en) 2010-09-27 2010-09-27 Skin whitening composition comprising complex herbal extract

Publications (2)

Publication Number Publication Date
KR20120031696A KR20120031696A (en) 2012-04-04
KR101238963B1 true KR101238963B1 (en) 2013-03-04

Family

ID=46135084

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100093236A KR101238963B1 (en) 2010-09-27 2010-09-27 Skin whitening composition comprising complex herbal extract

Country Status (1)

Country Link
KR (1) KR101238963B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030020811A (en) * 2001-09-04 2003-03-10 최상숙 Whitening cosmetics containing natural extracts
KR100602684B1 (en) * 2005-04-14 2006-07-20 인하대학교 산학협력단 Cosmetic composition comprising extract of erigeron breviscapus for whitening

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030020811A (en) * 2001-09-04 2003-03-10 최상숙 Whitening cosmetics containing natural extracts
KR100602684B1 (en) * 2005-04-14 2006-07-20 인하대학교 산학협력단 Cosmetic composition comprising extract of erigeron breviscapus for whitening

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
경원대학교 석사학위논문 "대황의 Elastase 활성 억제와 Tyrosinase 억제연구"(2007.12.) *
경원대학교 석사학위논문 "대황의 Elastase 활성 억제와 Tyrosinase 억제연구"(2007.12.)*
영남대학교 석사학위논문 "계피로부터 멜라닌 생성 억제 성분의 분리"(2007.12.) *
영남대학교 석사학위논문 "계피로부터 멜라닌 생성 억제 성분의 분리"(2007.12.)*

Also Published As

Publication number Publication date
KR20120031696A (en) 2012-04-04

Similar Documents

Publication Publication Date Title
KR100828193B1 (en) Composition comprising an extract of nelumbo nucifera gaertner showing skin whitening, anti-aging and anti-wrinkle activity
KR101086736B1 (en) Composition comprising a crude complex herb extract showing anti-aging and anti-wrinkle activity
KR100715485B1 (en) Cosmetic composition comprising the root extract of nymphaea tetragona having skin whitening and anti-aging activity
KR101143820B1 (en) Cosmetic composition comprising an extract of Aster ageratoides Turcz. var. ageratoides having whitening activities
KR20100094614A (en) Cosmetic composition comprising an extract of black garlic having skin whitening and wrinkle improving activity
KR100776346B1 (en) A composition comprising an extract eclipta prostrata l., rehmannia glutinosa liboschtz var. purpurea makino, polygonum multiflorium thunb. and pinellia ternata breit. showing anti-dandruff and anti-inflammatory activity
KR20130062112A (en) A topical composition comprising the extract of cyperus rotundus l as an active ingredient for preventing and treating inflammatory disease
KR101001578B1 (en) Composition comprising an extract of Carex humilis Leyss or ?-viniferin compound isolated therefrom for skin whitening
KR101243219B1 (en) Skin whitening and anti-wrinkle composition comprising a fermented plant extract in Ulleung island
KR101094306B1 (en) A composition comprising thymoquinone compounds having skin whitening activity
KR20090097483A (en) Composition comprising the mixed extract comprising mylabris sidae fabricius showing reduced toxicity for treating and improving leukoplakia
KR100865071B1 (en) Composition comprising the saururus chinensis extract or compound isolated therefrom for skin whitening
KR20130062113A (en) A topical composition comprising the extract of schizonepta tenuifolia as an active ingredient for preventing and treating inflammatory disease
KR101179589B1 (en) Composition comprising an extract of Magnolia officinalis Rehd. et Wils. or 4-O-methylhonokiol compound isolated therefrom for skin whitening
KR20130062111A (en) A topical composition comprising the seed extract of carthamus tinctorius as an active ingredient for preventing and treating inflammatory disease
KR20140116666A (en) Skin whitening and anti-skin aging composition comprising complex herbal extract
KR100931528B1 (en) Skin Whitening Composition Containing Radix Extract as Active Ingredient
KR101238963B1 (en) Skin whitening composition comprising complex herbal extract
KR101230588B1 (en) Cosmetics Composite
KR101536224B1 (en) A composition comprising the fruit extract of Platycarya strobilacea having skin whiting activity
KR100622286B1 (en) Skin whitening composition comprising 5-hydroxytryptophan as an active ingredient
KR100756669B1 (en) Cosmetic composition comprising an extract of Persicae fructus having whitening activities
KR20210063048A (en) Medical composition comprising extract of Padina gymnospora for skin whitening
KR100829831B1 (en) A skin whitening compositions comprising natural plant extract
KR100714172B1 (en) Cosmetic composition having the anti-wrinkle activity

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160225

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20161216

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20180426

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20181224

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20191210

Year of fee payment: 8